This is a Validated Antibody Database (VAD) review about dog CDH2, based on 31 published articles (read how Labome selects the articles), using CDH2 antibody in all methods. It is aimed to help Labome visitors find the most suited CDH2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CDH2 synonym: NCAD; cadherin-2; neural cadherin

Invitrogen
mouse monoclonal (CH-19)
  • western blot; mouse; loading ...; fig 1a
In order to explore how ST8SIA2-mediated polysialylation influences oligodendrocyte differentiation and schizophrenia, Invitrogen CDH2 antibody (Thermo Scientific, MA1-91128) was used in western blot on mouse samples (fig 1a). Glia (2017) ncbi
rabbit polyclonal
  • immunocytochemistry; dog; fig 4
  • western blot; dog; fig 4
In order to study the differentiation and transformation of canine kidney MDCK cells cultured in either a 2D or 3D environment, Invitrogen CDH2 antibody (Invitrogen, 71-7100) was used in immunocytochemistry on dog samples (fig 4) and in western blot on dog samples (fig 4). Lab Invest (2010) ncbi
rabbit polyclonal
In order to demonstrate that p27 is expressed in proliferating cells, Invitrogen CDH2 antibody (Zymed, 71-7100) was used . BMC Clin Pathol (2005) ncbi
Cell Signaling Technology
rabbit polyclonal
  • western blot; human; loading ...; fig 2a
Cell Signaling Technology CDH2 antibody (Cell Signaling Technology, 4061) was used in western blot on human samples (fig 2a). elife (2019) ncbi
rabbit polyclonal
  • other; human; loading ...; fig 4c
Cell Signaling Technology CDH2 antibody (Cell Signaling, 4061) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
rabbit polyclonal
  • western blot; human; 1:500; loading ...; fig 4C
Cell Signaling Technology CDH2 antibody (Cell Signaling, 4061S) was used in western blot on human samples at 1:500 (fig 4C). Oncol Lett (2017) ncbi
rabbit polyclonal
  • western blot; mouse; 1:500; loading ...; fig s5b
In order to determine the impact of smooth muscle cell beta-catenin to vascular homeostasis and arterial injury, Cell Signaling Technology CDH2 antibody (Cell signaling, 4061) was used in western blot on mouse samples at 1:500 (fig s5b). Arterioscler Thromb Vasc Biol (2017) ncbi
rabbit polyclonal
  • reverse phase protein lysate microarray; human; loading ...; fig st6
In order to characterize the molecular identity of uterine carcinosarcomas., Cell Signaling Technology CDH2 antibody (CST, 4061) was used in reverse phase protein lysate microarray on human samples (fig st6). Cancer Cell (2017) ncbi
rabbit polyclonal
  • western blot; human; loading ...; fig 2c
In order to find RE1 silencing transcription factor regulates epithelial-mesenchymal transition and neuroendecrin cell stemness acquisition in hormone-refractory prostate cancer, Cell Signaling Technology CDH2 antibody (Cell signaling, 4061) was used in western blot on human samples (fig 2c). Sci Rep (2017) ncbi
rabbit polyclonal
  • western blot; human; loading ...
In order to analyze the context specificity of signaling networks within a causal conceptual framework using reverse-phase protein array time-course assays and network analysis approaches, Cell Signaling Technology CDH2 antibody (Cell Signaling Technology, 4061) was used in western blot on human samples . Cell Syst (2017) ncbi
rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig s3a
In order to elucidate how CELF1 governs the epithelial-to-mesenchymal transition, Cell Signaling Technology CDH2 antibody (Cell Signaling, 4061) was used in western blot on human samples at 1:1000 (fig s3a). Nat Commun (2016) ncbi
rabbit polyclonal
  • western blot; human; loading ...; fig 1e
Cell Signaling Technology CDH2 antibody (cell signalling, 4061S) was used in western blot on human samples (fig 1e). Oncotarget (2017) ncbi
rabbit polyclonal
  • western blot; human; 1:200; fig st1
In order to identify and characterize alterations in signal transduction that occur during the development Lapatinib resistance, Cell Signaling Technology CDH2 antibody (Cell Signaling, 4061) was used in western blot on human samples at 1:200 (fig st1). Nat Commun (2016) ncbi
rabbit polyclonal
  • western blot; human; fig 3D
Cell Signaling Technology CDH2 antibody (Cell Signaling, 4061) was used in western blot on human samples (fig 3D). Onco Targets Ther (2016) ncbi
rabbit polyclonal
  • western blot; human; fig 7a
In order to investigate the role of growth hormone in colon cancer, Cell Signaling Technology CDH2 antibody (Cell Signaling, 4061) was used in western blot on human samples (fig 7a). Proc Natl Acad Sci U S A (2016) ncbi
rabbit polyclonal
  • western blot; human; loading ...; fig 3b
In order to study the contribution of CCL7-induced epithelial-mesenchymal transition signaling to the progression and metastasis of colon cancer, Cell Signaling Technology CDH2 antibody (Cell Signaling, 4061) was used in western blot on human samples (fig 3b). Oncotarget (2016) ncbi
rabbit polyclonal
  • western blot; mouse; 1:1000; fig 2
Cell Signaling Technology CDH2 antibody (Cell Signaling, 4061) was used in western blot on mouse samples at 1:1000 (fig 2). PLoS ONE (2015) ncbi
rabbit polyclonal
  • western blot; human; fig 3
Cell Signaling Technology CDH2 antibody (Cell Signaling Tech, 4061) was used in western blot on human samples (fig 3). Oncotarget (2016) ncbi
rabbit polyclonal
  • western blot; mouse; 1:1000; fig 2
Cell Signaling Technology CDH2 antibody (Cell Signaling, 4061) was used in western blot on mouse samples at 1:1000 (fig 2). PLoS ONE (2015) ncbi
rabbit polyclonal
  • western blot; human; fig 1
Cell Signaling Technology CDH2 antibody (Cell Signaling, 4061) was used in western blot on human samples (fig 1). Oncotarget (2015) ncbi
rabbit polyclonal
  • western blot; mouse; fig 1d
In order to test if ZO-1-mediated diminution of polarity results in an epithelial-to-mesenchyme transition and increased metastatic potential, Cell Signaling Technology CDH2 antibody (Cell Signaling, 4061) was used in western blot on mouse samples (fig 1d). Oncogene (2016) ncbi
rabbit polyclonal
  • western blot; human; loading ...; fig 8
In order to report the effect of c-Met inhibition using neuroendocrine tumor cells, Cell Signaling Technology CDH2 antibody (Cell Signaling, 4061) was used in western blot on human samples (fig 8). Neuroendocrinology (2016) ncbi
rabbit polyclonal
  • western blot; human; 1:1000; fig 3
Cell Signaling Technology CDH2 antibody (Genetex, 4061) was used in western blot on human samples at 1:1000 (fig 3). Oncotarget (2015) ncbi
rabbit polyclonal
  • western blot; human; fig 1
Cell Signaling Technology CDH2 antibody (Cell Signaling Tech, 4061s) was used in western blot on human samples (fig 1). Int J Mol Med (2015) ncbi
rabbit polyclonal
  • western blot; human; fig 3
In order to elucidate the tumor suppressor function of BTG3, Cell Signaling Technology CDH2 antibody (Cell Signaling Technologies, 4061) was used in western blot on human samples (fig 3). Cell Death Dis (2015) ncbi
rabbit polyclonal
  • western blot; human; fig 1
Cell Signaling Technology CDH2 antibody (Cell Signalling Technology, 4061S) was used in western blot on human samples (fig 1). Cell Prolif (2014) ncbi
rabbit polyclonal
  • western blot; human
In order to study how phosphorylation alters COP1-binding sites of oncoproteins, Cell Signaling Technology CDH2 antibody (Cell Signaling, 4061) was used in western blot on human samples . Cancer Cell (2014) ncbi
rabbit polyclonal
  • western blot; human; 1:600
Cell Signaling Technology CDH2 antibody (Cell Signaling Technology, 4061s) was used in western blot on human samples at 1:600. Urol Oncol (2014) ncbi
rabbit polyclonal
  • western blot; human
Cell Signaling Technology CDH2 antibody (Cell Signaling Technology, 4061) was used in western blot on human samples . PLoS ONE (2014) ncbi
rabbit polyclonal
  • western blot; human
In order to show that uPAR regulates nasopharyngeal carcinoma NPC progression, Cell Signaling Technology CDH2 antibody (Cell Signaling Technology, 4061) was used in western blot on human samples . Cell Cycle (2014) ncbi
rabbit polyclonal
  • western blot; human
Cell Signaling Technology CDH2 antibody (Cell Signaling, 4061p) was used in western blot on human samples . Cancer Res (2014) ncbi
Articles Reviewed
  1. Adams C, Htwe H, Marsh T, Wang A, Montoya M, Subbaraj L, et al. Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer. elife. 2019;8: pubmed publisher
  2. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  3. Hu X, Zhang Z, Liang Z, Xie D, Zhang T, Yu D, et al. Downregulation of feline sarcoma-related protein inhibits cell migration, invasion and epithelial-mesenchymal transition via the ERK/AP-1 pathway in bladder urothelial cell carcinoma. Oncol Lett. 2017;13:686-694 pubmed publisher
  4. Riascos Bernal D, Chinnasamy P, Gross J, Almonte V, Egaña Gorroño L, Parikh D, et al. Inhibition of Smooth Muscle ?-Catenin Hinders Neointima Formation After Vascular Injury. Arterioscler Thromb Vasc Biol. 2017;37:879-888 pubmed publisher
  5. Cherniack A, Shen H, Walter V, Stewart C, Murray B, Bowlby R, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31:411-423 pubmed publisher
  6. Chang Y, Lin T, Campbell M, Pan C, Lee S, Lee H, et al. REST is a crucial regulator for acquiring EMT-like and stemness phenotypes in hormone-refractory prostate cancer. Sci Rep. 2017;7:42795 pubmed publisher
  7. Hill S, Nesser N, Johnson Camacho K, Jeffress M, Johnson A, Boniface C, et al. Context Specificity in Causal Signaling Networks Revealed by Phosphoprotein Profiling. Cell Syst. 2017;4:73-83.e10 pubmed publisher
  8. Chaudhury A, Cheema S, Fachini J, Kongchan N, Lu G, Simon L, et al. CELF1 is a central node in post-transcriptional regulatory programmes underlying EMT. Nat Commun. 2016;7:13362 pubmed publisher
  9. Gong F, Guo Y, Niu Y, Jin J, Zhang X, Shi X, et al. Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma. Oncotarget. 2017;8:315-328 pubmed publisher
  10. Treindl F, Ruprecht B, Beiter Y, Schultz S, Döttinger A, Staebler A, et al. A bead-based western for high-throughput cellular signal transduction analyses. Nat Commun. 2016;7:12852 pubmed publisher
  11. Szewczyk L, Brozko N, Nagalski A, Röckle I, Werneburg S, Hildebrandt H, et al. ST8SIA2 promotes oligodendrocyte differentiation and the integrity of myelin and axons. Glia. 2017;65:34-49 pubmed publisher
  12. Hong L, Pan F, Jiang H, Zhang L, Liu Y, Cai C, et al. miR-125b inhibited epithelial-mesenchymal transition of triple-negative breast cancer by targeting MAP2K7. Onco Targets Ther. 2016;9:2639-48 pubmed publisher
  13. Chesnokova V, Zonis S, Zhou C, Recouvreux M, Ben Shlomo A, Araki T, et al. Growth hormone is permissive for neoplastic colon growth. Proc Natl Acad Sci U S A. 2016;113:E3250-9 pubmed publisher
  14. Lee Y, Kim S, Song S, Hong H, Lee Y, Oh B, et al. Crosstalk between CCL7 and CCR3 promotes metastasis of colon cancer cells via ERK-JNK signaling pathways. Oncotarget. 2016;7:36842-36853 pubmed publisher
  15. Maria Z, Campolo A, Lacombe V. Diabetes Alters the Expression and Translocation of the Insulin-Sensitive Glucose Transporters 4 and 8 in the Atria. PLoS ONE. 2015;10:e0146033 pubmed publisher
  16. Noh H, Hah Y, Ha J, Kang M, Zada S, Rha S, et al. Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity. Oncotarget. 2016;7:4632-46 pubmed publisher
  17. Jackson E, Rendina Ruedy E, Smith B, Lacombe V. Loss of Toll-Like Receptor 4 Function Partially Protects against Peripheral and Cardiac Glucose Metabolic Derangements During a Long-Term High-Fat Diet. PLoS ONE. 2015;10:e0142077 pubmed publisher
  18. Qin W, Li C, Zheng W, Guo Q, Zhang Y, Kang M, et al. Inhibition of autophagy promotes metastasis and glycolysis by inducing ROS in gastric cancer cells. Oncotarget. 2015;6:39839-54 pubmed publisher
  19. Nagaoka K, Fujii K, Zhang H, Usuda K, Watanabe G, Ivshina M, et al. CPEB1 mediates epithelial-to-mesenchyme transition and breast cancer metastasis. Oncogene. 2016;35:2893-901 pubmed publisher
  20. Reuther C, Heinzle V, Spampatti M, Vlotides G, de Toni E, Spöttl G, et al. Cabozantinib and Tivantinib, but Not INC280, Induce Antiproliferative and Antimigratory Effects in Human Neuroendocrine Tumor Cells in vitro: Evidence for 'Off-Target' Effects Not Mediated by c-Met Inhibition. Neuroendocrinology. 2016;103:383-401 pubmed publisher
  21. Zucha M, Wu A, Lee W, Wang L, Lin W, Yuan C, et al. Bruton's tyrosine kinase (Btk) inhibitor ibrutinib suppresses stem-like traits in ovarian cancer. Oncotarget. 2015;6:13255-68 pubmed
  22. Li L, Qi L, Liang Z, Song W, Liu Y, Wang Y, et al. Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells. Int J Mol Med. 2015;36:113-22 pubmed publisher
  23. Cheng Y, Chen P, Chiang H, Suen C, Hwang M, Lin T, et al. Candidate tumor suppressor B-cell translocation gene 3 impedes neoplastic progression by suppression of AKT. Cell Death Dis. 2015;6:e1584 pubmed publisher
  24. Tang J, Shen L, Yang Q, Zhang C. Overexpression of metadherin mediates metastasis of osteosarcoma by regulating epithelial-mesenchymal transition. Cell Prolif. 2014;47:427-34 pubmed publisher
  25. Lu G, Zhang Q, Huang Y, Song J, Tomaino R, Ehrenberger T, et al. Phosphorylation of ETS1 by Src family kinases prevents its recognition by the COP1 tumor suppressor. Cancer Cell. 2014;26:222-34 pubmed publisher
  26. Liang W, Hao Z, Han J, Zhu D, Jin Z, Xie W. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition. Urol Oncol. 2014;32:855-63 pubmed publisher
  27. Subramani R, Lopez Valdez R, Arumugam A, Nandy S, Boopalan T, Lakshmanaswamy R. Targeting insulin-like growth factor 1 receptor inhibits pancreatic cancer growth and metastasis. PLoS ONE. 2014;9:e97016 pubmed publisher
  28. Bao Y, Cao X, Luo D, Sun R, Peng L, Wang L, et al. Urokinase-type plasminogen activator receptor signaling is critical in nasopharyngeal carcinoma cell growth and metastasis. Cell Cycle. 2014;13:1958-69 pubmed publisher
  29. Wu K, Chen K, Wang C, Jiao X, Wang L, Zhou J, et al. Cell fate factor DACH1 represses YB-1-mediated oncogenic transcription and translation. Cancer Res. 2014;74:829-39 pubmed publisher
  30. Töyli M, Rosberg Kulha L, Capra J, Vuoristo J, Eskelinen S. Different responses in transformation of MDCK cells in 2D and 3D culture by v-Src as revealed by microarray techniques, RT-PCR and functional assays. Lab Invest. 2010;90:915-28 pubmed publisher
  31. Troncone G, Martinez J, Iaccarino A, Zeppa P, Caleo A, Russo M, et al. p27Kip1 is expressed in proliferating cells in its form phosphorylated on threonine 187. BMC Clin Pathol. 2005;5:3 pubmed